DrugPatentWatch Database Preview
Profile for United Kingdom Patent: 2506085
US Patent Family Members and Approved Drugs for United Kingdom Patent: 2506085
US Patent Number | US Expiration Date | US Applicant | US Tradename | Generic Name |
---|---|---|---|---|
➤ Sign Up | Sep 4, 2032 | Abbvie Inc | VIEKIRA XR | dasabuvir sodium; ombitasvir; paritaprevir; ritonavir |
➤ Sign Up | Sep 4, 2032 | Abbvie Inc | VIEKIRA PAK (COPACKAGED) | dasabuvir sodium ; ombitasvir; paritaprevir; ritonavir |
➤ Sign Up | Sep 4, 2032 | Abbvie Inc | VIEKIRA XR | dasabuvir sodium; ombitasvir; paritaprevir; ritonavir |
➤ Sign Up | Sep 4, 2032 | Abbvie Inc | VIEKIRA PAK (COPACKAGED) | dasabuvir sodium ; ombitasvir; paritaprevir; ritonavir |
US Patent Number | US Expiration Date | US Applicant | US Tradename | Generic Name |